Angiogenesis and chronic inflammation; the potential for novel therapeutic approaches in chronic liver disease

Journal of Hepatology

Volumn 42, Issue 1, 2005, Pages 7-11

  Lai, W K ^a   Adams, David H ^a  

^a Liver Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANTIINFLAMMATORY AGENT; BEVACIZUMAB; ENDOSTATIN; IMMUNOSUPPRESSIVE AGENT; MATRIX METALLOPROTEINASE INHIBITOR; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ANTIBODY; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; CHRONIC INFLAMMATION; CHRONIC LIVER DISEASE; DRUG EFFICACY; EDITORIAL; HEPATITIS; HUMAN; NONHUMAN; PRIORITY JOURNAL;

CHEMOKINES, CC; CHRONIC DISEASE; FIBROBLAST GROWTH FACTOR 1; HUMANS; LIVER CIRRHOSIS, BILIARY; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 11144296764     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.11.008     Document Type: Editorial

References (65)

1. J. Medina, P. Sanz-Cameno, L. García-Buey, S. Martín- Vílchez, M. López-Cabrera, and R. Moreno-Otero Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study J Hepatol 42 2005 124 131
2. C. Garcia-Monzon, F. Sanchez-Madrid, L. Garcia-Buey, A. Garcia-Arroyo, A. Garcia-Sanchez, and R. Moreno-Otero Enhanced expression of vascular adhesion molecules in chronic viral hepatitis. Evidence of neoangiogenesis in portal tracts Gastroenterology 108 1995 231 241
3. A.J. Grant, S. Goddard, J. Ahmed-Choudhury, G. Reynolds, D.G. Jackson, and M. Briskin Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease Am J Pathol 160 2002 1445 1455
4. A.E. Koch Review: angiogenesis: implications for rheumatoid arthritis Arthritis Rheum 41 1998 951 962
5. N.N. Nissen, P.J. Polverini, A.E. Koch, M.V. Volin, R.L. Gamelli, and L.A. DiPietro Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing Am J Pathol 152 1998 1445 1452
6. I.J. Fidler, and L.M. Ellis The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 79 1994 185 188
7. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
8. Y. Lei, H.K. Haider, J. Shujia, and E.S. Sim Therapeutic angiogenesis. Devising new strategies based on past experiences Basic Res Cardiol 99 2004 121 132
9. J. Street, M. Bao, L. DeGuzman, S. Bunting, F.V. Peale Jr, and N. Ferrara Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover Proc Natl Acad Sci USA 99 2002 9656 9661
10. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
11. J. Holash, P.C. Maisonpierre, D. Compton, P. Boland, C.R. Alexander, and D. Zagzag Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 1999 1994 1998
12. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
13. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr Rev 18 1997 4 25
14. M.S. Pepper, N. Ferrara, L. Orci, and R. Montesano Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells Biochem Biophys Res Commun 181 1991 902 906
15. E.N. Unemori, N. Ferrara, E.A. Bauer, and E.P. Amento Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells J Cell Physiol 153 1992 557 562
16. D.T. Connolly, D.M. Heuvelman, R. Nelson, J.V. Olander, B.L. Eppley, and J.J. Delfino Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis J Clin Invest 84 1989 1470 1478
17. R.J. Melder, G.C. Koenig, B.P. Witwer, N. Safabakhsh, L.L. Munn, and R.K. Jain During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium Nat Med 2 1996 992 997
18. M. Clauss, M. Gerlach, H. Gerlach, J. Brett, F. Wang, and P.C. Familletti Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration J Exp Med 172 1990 1535 1545
19. L. Pertovaara, A. Kaipainen, T. Mustonen, A. Orpana, N. Ferrara, and O. Saksela Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells J Biol Chem 269 1994 6271 6274
20. J. Li, M.A. Perrella, J.C. Tsai, S.F. Yet, C.M. Hsieh, and M. Yoshizumi Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells J Biol Chem 270 1995 308 312
21. T. Cohen, D. Nahari, L.W. Cerem, G. Neufeld, and B.Z. Levi Interleukin 6 induces the expression of vascular endothelial growth factor J Biol Chem 271 1996 736 741
22. J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, and C. Van Kooten The CD40 antigen and its ligand Annu Rev Immunol 12 1994 881 922
23. S.C. Afford, S. Randhawa, A.G. Eliopoulos, S.G. Hubscher, L.S. Young, and D.H. Adams CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection J Exp Med 189 1999 441 446
24. V. Henn, J.R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, and G. Muller-Berghaus CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 391 1998 591 594
25. L.S. Young, A.G. Eliopoulos, N.J. Gallagher, and C.W. Dawson CD40 and epithelial cells: across the great divide Immunol Today 19 1998 502 506
26. S.C. Afford, J. Ahmed-Choudhury, S. Randhawa, C. Russell, J. Youster, and H.A. Crosby CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells Fed Am Soc Exp Biol J 15 2001 2345 2354
27. J. Ahmed-Choudhury, C.L. Russell, S. Randhawa, L.S. Young, D.H. Adams, and S.C. Afford Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation Mol Biol Cell 14 2003 1334 1345
28. N. Malik, B.W. Greenfield, A.F. Wahl, and P.A. Kiener Activation of human monocytes through CD40 induces matrix metalloproteinases J Immunol 156 1996 3952 3960
29. M.J. Yellin, S. Winikoff, S.M. Fortune, D. Baum, M.K. Crow, and S. Lederman Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation J Leukoc Biol 58 1995 209 216
30. C.S. Cho, M.L. Cho, S.Y. Min, W.U. Kim, D.J. Min, and S.S. Lee CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor J Immunol 164 2000 5055 5061
31. C.D. Buckley, D. Pilling, J.M. Lord, A.N. Akbar, D. Scheel-Toellner, and M. Salmon Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation Trends Immunol 22 2001 199 204
32. C.D. Buckley, N. Amft, P.F. Bradfield, D. Pilling, E. Ross, and F. Arenzana-Seisdedos Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium J Immunol 165 2000 3423 3429
33. K. Hiasa, M. Ishibashi, K. Ohtani, S. Inoue, Q. Zhao, and S. Kitamoto Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization Circulation 109 2004 2454 2461
34. R.M. Strieter, P.J. Polverini, D.A. Arenberg, and S.L. Kunkel The role of cxc chemokines as regulators of angiogenesis Shock 4 1995 155 160
35. J. Folkman, M. Klagsbrun, J. Sasse, M. Wadzinski, D. Ingber, and I. Vlodavsky A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane Am J Pathol 130 1988 393 400
36. M.C. Puri, J. Rossant, K. Alitalo, A. Bernstein, and J. Partanen The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells Eur Mol Biol Org J 14 1995 5884 5891
37. T.I. Koblizek, C. Weiss, G.D. Yancopoulos, U. Deutsch, and W. Risau Angiopoietin-1 induces sprouting angiogenesis in vitro Curr Biol 8 1998 529 532
38. T.N. Sato, Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, and M. Gendron-Maguire Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation Nature 376 1995 70 74
39. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
40. F. Okada, J.W. Rak, B.S. Croix, B. Lieubeau, M. Kaya, and L. Roncari Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells Proc Natl Acad Sci USA 95 1998 3609 3614
41. N.M. Mazure, E.Y. Chen, P. Yeh, K.R. Laderoute, and A.J. Giaccia Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression Cancer Res 56 1996 3436 3440
42. E.G. Van Meir, P.J. Polverini, V.R. Chazin, H.J. Su Huang, N. de Tribolet, and W.K. Cavenee Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells Nat Genet 8 1994 171 176
43. J.R. Conejo-Garcia, F. Benencia, M.C. Courreges, E. Kang, A. Mohamed-Hadley, and R.J. Buckanovich Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A Nat Med 10 2004 950 958
44. F. Kabbinavar, H.I. Hurwitz, L. Fehrenbacher, N.J. Meropol, W.F. Novotny, and G. Lieberman Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer J Clin Oncol 21 2003 60 65
45. S. Wojtowicz-Praga, J. Torri, M. Johnson, V. Steen, J. Marshall, and E. Ness Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer J Clin Oncol 16 1998 2150 2156
46. M.S. O'Reilly Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth EXS 79 273-94 1997 273 294
47. J.P. Eder Jr, J.G. Supko, J.W. Clark, T.A. Puchalski, R. Garcia-Carbonero, and D.P. Ryan Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily J Clin Oncol 20 2002 3772 3784
48. R.J. D'Amato, M.S. Loughnan, E. Flynn, and J. Folkman Thalidomide is an inhibitor of angiogenesis Proc Natl Acad Sci USA 91 1994 4082 4085
49. T. Ezaki, P. Baluk, G. Thurston, A. La Barbara, C. Woo, and D.M. McDonald Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation Am J Pathol 158 2001 2043 2055
50. S.C. Ballara, J.M. Miotla, and E.M. Paleolog New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders Int J Exp Pathol 80 1999 235 250
51. X.W. Bian, J.H. Chen, X.F. Jiang, J.S. Bai, Q.L. Wang, and X. Zhang Angiogenesis as an immunopharmacologic target in inflammation and cancer Int Immunopharmacol 4 2004 1537 1547
52. A. Kratz, A. Campos-Neto, M.S. Hanson, and N.H. Ruddle Chronic inflammation caused by lymphotoxin is lymphoid neogenesis J Exp Med 183 1996 1461 1472
53. N.H. Ruddle Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development Immunol Res 19 1999 119 125
54. B. Eksteen, A.J. Grant, A. Miles, P.F. Lalor, M. Briskin, and D.F. Adams Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut homing lymphocytes to the liver in PSC J Exp Med 2004 in press
55. J.F. Mosnier, C. Degott, P. Marcellin, D. Henin, S. Erlinger, and J.P. Benhamou The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study Hepatology 17 1993 366 371
56. R. Sacca, C.A. Cuff, W. Lesslauer, and N.H. Ruddle Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling J Immunol 160 1998 485 491
57. K. Shimamatsu, and I.R. Wanless Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver Hepatology 26 1997 343 350
58. E. Taniguchi, S. Sakisaka, K. Matsuo, K. Tanikawa, and M. Sata Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats J Histochem Cytochem 49 2001 121 130
59. J.P. Girard, and T.A. Springer High endothelial venules (HEVs): specialized endothelium for lymphocyte migration Immunol Today 16 1995 449 457
60. P.J. Scheuer, P. Ashrafzadeh, S. Sherlock, D. Brown, and G.M. Dusheiko The pathology of hepatitis C Hepatology 15 1992 567 571
61. M.A. Freni, D. Artuso, G. Gerken, C. Spanti, T. Marafioti, and N. Alessi Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity Hepatology 22 1995 389 394
62. J.P. Girard, and T.A. Springer High endothelial venules (HEVs): specialized endothelium for lymphocyte migration Immunol Today 16 1995 449 457
63. H. Yoneyama, K. Matsuno, Y. Zhang, M. Murai, M. Itakura, and S. Ishikawa Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease J Exp Med 193 2001 35 49
64. M.T. Hendrickse, E. Rigney, M.H. Giaffer, I. Soomro, D.R. Triger, and J.C. Underwood Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial Gastroenterology 117 1999 400 407
65. Y.H. Oo, and J. Neuberger Options for treatment of primary biliary cirrhosis Drugs 64 2004 2261 2271